Fermentation-based synthetic biology platform for sustainable specialty chemicals
Amyris manufactures renewable ingredients via fermentation across pharma, beauty, and industrial markets. The tech stack is operations-heavy (SAP, MES, Power BI, HPLC) with no AI/ML or modern data infrastructure, while hiring accelerates across engineering and manufacturing — a pattern matching active scale-up work: pilot fermentation, process transfer, and capex workflow automation. Pain points cluster around production cost reduction and process optimization, signaling the company is bottlenecked on manufacturing efficiency rather than discovery.
Amyris is a synthetic biology company built around fermentation-based production of specialty chemicals and ingredients. Founded in 2003, the company operates a vertically integrated manufacturing platform that partners with customers across pharmaceuticals, beauty, flavors and fragrances, and industrial sectors to develop and scale sustainable alternatives to petrochemical and natural-derived inputs. Products are currently embedded in thousands of consumer-facing goods. The Emeryville headquarters anchors R&D and operations, with manufacturing and process development distributed across U.S. and Brazil sites.
Core operations tools: SAP (MM, PM), MES, HPLC, Power BI. Enterprise infrastructure: Azure, Microsoft 365, Jira, Confluence, Active Directory. No AI/ML or modern data platforms in use.
Pilot-scale fermentation experiments, process scale-up and scale-down initiatives, technology transfer, and internal process standardization (FP&A, capex approval, safety systems).
Other companies in the same industry, closest in size